<DOC>
	<DOCNO>NCT00943176</DOCNO>
	<brief_summary>The purpose study evaluate use modafinil treatment fatigue patient Primary Biliary Cirrhosis . The general aim study identify safe effective therapy fatigue patient primary biliary cirrhosis .</brief_summary>
	<brief_title>Modafinil Treatment Fatigue Patients With Primary Biliary Cirrhosis ( PBC )</brief_title>
	<detailed_description>The general aim study identify safe effective therapy fatigue patient primary biliary cirrhosis . Specific aim include : 1 ) determine safety profile modafinil patient primary biliary cirrhosis ; 2 ) evaluate beneficial effect modafinil patient primary biliary cirrhosis fatigue document well-validated questionnaire ( Fisk Fatigue Severity Score ) apply begin end study period ; 3 ) compare performance three questionnaire ( Fisk Fatigue Severity Score , Fatigue Severity Scale fatigue domain PBC-40 ) instrument determine benefit therapeutic intervention fatigue establish minimally important clinical difference measure fatigue .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Primary biliary cirrhosis define present 2 3 follow criterion meet : Chronic cholestatic liver disease great 6 month alkaline phosphatase level great 1.5 time upper limit normal prior UDCA treatment . Positive AMA titer great equal 1:40 AMA great 0.1U . Liver histology past feature consistent diagnostic PBC . A previous ultrasound , compute tomography ( CT ) , cholangiography biliary tree excludes biliary obstruction . Verbal report fatigue great 6 month . Patients serious coexistent condition preexist advanced malignancy severe cardiopulmonary disease would expect limit expectancy less three year . Findings highly suggestive liver disease etiology chronic alcoholic liver disease , chronic hepatitis B C infection , hemochromatosis , Wilson 's disease , 1antitrypsin deficiency , nonalcoholic steatohepatitis sclerosing cholangitis . Treatment underlie PBC modify precede six month . Anticipated need transplantation one year ( Mayo survival model &lt; 80 % oneyear survival without transplant ) MELD 15 . Recurrent variceal bleeding , presence diureticresistant ascites , spontaneous encephalopathy . Active drug alcohol use . History drug and/or stimulant ( e.g . methylphenidate , amphetamine , cocaine ) abuse . Serum bilirubin &gt; 4 mg/dl . Serum creatinine 1.4 mg/dl . Pregnancy . Breastfeeding . Inability unwillingness practice contraceptive measure prevention pregnancy appropriate . Other fatigue relate diagnosis anemia , thyroid disease , renal failure , use betablockers untreated depression . Known hypersensitivity modafinil . Uncontrolled hypertension . Patients hypertension leave ventricular hypertrophy document ECG last 2 year . Recent ( &lt; 6 month ) history myocardial infarction unstable angina . Patients history psychosis . Patients receive cyclosporine , warfarin , tricyclic agent , carbamazepine , phenobarbital , rifampin , ketoconazole itraconazole last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Fatigue</keyword>
</DOC>